Trial
NCT04453293
Immunization With BCG Vaccine to Prevent Tuberculosis Infection
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Henry M. Jackson Foundation for the Advancement of Military Medicine
Collaborators
United States Department of Defense; Uniformed Services University of the Health Sciences
Condition
Tuberculosis Infection
Intervention
BCG (Tokyo 172) vaccine
Why stopped
The sponsor has elected to discontinue/terminate the study prematurely due to slower-than-anticipated recruitment and limited remaining research funding.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-23